INS and depressive symptom measurement: Khawagi et al [10] demonstrated that insulin signaling dysregulation in T2DM impairs brain serotonin signaling, increasing depression risk; conversely, depressive states disrupt insulin homeostasis via neuroendocrine mechanisms, establishing a bidirectional relationship between metabolic and psychological pathways.